Clinical trial
Docetaxel in Treating Patients With Non-Small Cell Lung Cancer
NCT00022022 · Istituto Nazionale per lo Studio e la Cura dei Tumori, Other · Unknown status
Key facts
| NCT number | NCT00022022 |
|---|---|
| Title | Docetaxel in Treating Patients With Non-Small Cell Lung Cancer |
| Official title | Docetaxel In Second-Line Treatment Of Advanced Non-Small-Cell Lung Cancer - The Distal Study |
| Lead sponsor | Istituto Nazionale per lo Studio e la Cura dei Tumori, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Procedure |
| Interventions | docetaxel, quality-of-life assessment |
| Enrollment | 200 |
| Start date | Dec 1, 2000 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 18, 2013 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: